Literature DB >> 35326346

Autistic-like Behaviors Associated with a Novel Non-Canonical Splice-Site DDX3X Variant: A Case Report of a Rare Clinical Syndrome.

Urszula Stefaniak1, Roksana Malak2, Ewa Mojs1, Włodzimierz Samborski2.   

Abstract

BACKGROUND: Heterozygous pathogenic variants in the DDX3X gene account for 1-3% of females with intellectual and developmental disabilities (IDD). The clinical presentation is variable, including a wide range of neurological and behavioral deficits and structural defects of the brain. Approximately 52% of affected females remain nonverbal after five years of age. CASE
PRESENTATION: We report a 7 year old nonverbal female with a likely novel de novo pathogenic heterozygous variant in the DDX3X gene affecting the non-canonical splice-site in the intron 1 (NM_001356:c.45+12G>A). The patient presents with features typical for the DDX3X phenotype, such as: movement disorders, behavioral problems, a diagnosis of autism spectrum disorder (ASD), and some other features uncommon for DDX3X such as: muscle hypertonia and spinal asymmetry evaluated through the scoliometer.
CONCLUSIONS: Due to its rare occurrence, the clinical picture of DDX3X syndrome is yet to be fully determined. So far, behavioral disorders, including those from ASD, and neurological abnormalities seem to be the dominant features of this disorder.

Entities:  

Keywords:  DDX3X; autism spectrum disorders (ASD); intellectual and developmental disabilities (IDD); rare disease

Year:  2022        PMID: 35326346      PMCID: PMC8946163          DOI: 10.3390/brainsci12030390

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


1. Introduction

DDX3X is a ubiquitously expressed ATPase on the X chromosome, DDX3X. The mutations of DDX3X are known to implicate diseases such as viral infections, inflammation, as well as intellectual and developmental disabilities (IDD) [1,2]. Mutations in DDX3X may participate in autism-spectrum disorders (ASD), mostly in females [3]. Referring to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), ASD mostly affects communication and behavior [4]. Nowadays, the prevalence of ASD is increasing [5]. Worldwide, up to 769 cases of DDX3X gene-specific conditions related to ASD have been identified, specifically in 38 males and 731 females across 50 countries [6]. Predominantly prevalent in females, this mutation is inherited in an X-linked dominant pattern and is seldom inherited in males in an X-linked recessive pattern [7]. About 1–3% of females with unexplained intellectual and developmental disabilities IDD carry de novo pathogenic variants in the DDX3X gene [7]. Patients present varying degrees of symptoms typical for IDD, including epilepsy, behavior typical for children with autism spectrum disorder, sensory deficits, delays in motor development, microcephaly, and muscle hypotonia. The most common brain malformations can be found in the corpus callosum hypoplasia, polymicrogyria (PMG), and ventricular enlargement [8]. Facial dysmorphism is the phenotypic feature that usually leads parents and caregivers to seek an alternative diagnosis. Nowadays, pathogenic DDX3X variants are predominantly detected in females. Only a few de novo DDX3X mutations have been identified in the male population [9]. The DDX3X gene located on the X chromosome encodes a conserved DEAD-box RNA-helicase [10]. This gene plays an important role in a variety of fundamental cellular processes including transcription, splicing, RNA transport and translation [7]. We report a seven year old girl with ASD features, delayed psychomotor development, lack of speech, limited and repetitive patterns of behavior, celiac disease, and sensory integration (SI) processing problems with a novel de novo DDX3X variant c.45+12G>A. We would like to present our findings because in previous research we did not find enough information about the musculoskeletal system or sensory integration processing disorders. There is a study by Blok et al., (2015) that showed that females with DDX3X presented joint laxity and hyperactivity [7]. Even though previous papers presented information about the musculoskeletal system and IDD, we did not find any study that showed how we could measure it. Therefore, we think that the present article may be valid for clinicians, therapists, as well as for parents who would like to improve the intellectual and motor condition of their children with DDX3X.

2. Materials and Methods

The patient, who is currently 7 years old, was the first-born child. Her parents did not have any other children. There were no reported miscarriages before or after giving birth. In reference to the interview with the patient’s parents, there were no genetic conditions in this family, children with IDD beyond the second generation, or a diagnosis of epilepsy. The patient was born at 40 + 4 gestational weeks, as a result of an uneventful pregnancy, characterized by regular growth, morphology, and fetal movements. She was born via spontaneous vertex delivery. As a result of a nuchal cord, she was silent and apneic at birth, however engaged in independent respiration following the removal of the umbilical cord and aspiration of the amniotic fluid. Her clinical features are reported in Table 1. Her birth weight was 3680 g, and she had a body length of 54 cm, an occipitofrontal circumference of 34 cm and Apgar scores of 8 at the 5th and 9 at the10th minute of life. A hearing test was conducted and did not show any abnormalities. The same test was repeated at 3 years of age, and again failed to show any shortcomings.
Table 1

Clinical features of the reported individual compared with the characteristics of clinical signs associated with DDX3X syndrome.

Clinical Signs in the Presented CaseDDX3X Syndrome Clinical Signs
Development
yesDevelopmental delay
noIntellectual disability
yesSpeech delay
Growth
noFailure to thrive
noShort stature
noMicrocephaly
yesBrachycephaly
Neurologic/behavioral
noSeizures
noHypotonia
noHypertonia/spasticity
noMixed hypo and hypertonia
yesSleep disturbance
noMovement disorders/leg spasticity
yesBehavior disorders/autism spectrum disorder/aggression
noHyperreflexia
Brain MRI
noPolymicrogyria
noCorpus callosum hypoplasia/agenesis
noVentricular enlargement
noKey-hole shaped temporal horns
noColpocephaly
noDelayed myelination/decreased cortical white
noSmall pons
noSmall interior vermis
yesChanges in temporal lobe- cyst
Sensory
noVision problems (strabismus, coloboma, astigmatism, nystagmus)
noHearing problems
yesHigh pain threshold
yesTemperature dysregulation
Facial dysmorphism
noShort/down-slanting palpebral fissure
noHypertelorism/telecanthus
noEpicanthal folds
flattened faceElongated/flattened face/triangular face
high foreheadHigh/broad forehead
NoWide nasal bridge/bulbous tip
narrow noseShort/narrow nose, anteverted nares
noMicrognathia
noHigh arched palate
noThin upper lip
noLow set/protruding/wide ears
noSmooth/long philtrum
noCleft lip/palate
noMacroglossia
Other
noCongenital cardiac defects
not applicablePrecocious puberty
noFeeding difficulties (gastro-esophageal reflux/swallowing)
noJoint hyperlaxity
yesScoliosis/asymmetry in the spine
noMalformations of the hands
noSkin pigmentation anomalies
noLoss/reduced subcutaneous fat
YesHigher Inflammatory cytokine profile
yesIL-1β
yesIL-6
yesIL-10
In the first twelve months of life, the patient’s psychomotor development was normal according to her age. An evaluation at three years of age revealed behaviors related to ASD, such as stereotypy, problems with imitation movements that suggested problems with mirror neurons, and dysfunction with sensory processing: tactile defensiveness, lack of speech, and occasional sleep disturbances. Simultaneously, behaviors such as cognitive curiosity, a strong willingness to spontaneously explore the environment, a cheerful disposition and personality, and a fascination with water did not align with features typical of ASD. However, this patient started to attend a kindergarten for children with ASD. A fascination with water transformed into obsessive behaviors with water such as taking off clothing and putting them in the sink. In addition, growth parameters were considered normal, and the patient was slightly taller and heavier than other females of the same age in the normative population. At the age of 3 years and 2 months, she weighed 20,300 g (90th percentile) and was 106 cm tall (50th percentile). At the age of four, she was diagnosed with celiac disease, which confirmed the cause of her severe constipation in earlier years. The patient’s brain Magnetic Resonance Imaging MRI examination did not reveal any abnormalities in two examinations performed at four and then again at six years of age. In both scans of the middle bottom section of the skull, an arachnoid cyst shaping the front surface of the temporal lobe had been found on the right side (Figure 1, Figure 2 and Figure 3). Moreover, in the right temporal lobe, a slight delayed myelination of white matter and segmented thickness of the cortical layer had been detected (Figure 4). Due to the patient being awake when performing an electroencephalogram (EEG) and not tolerating keeping the electrodes on her scalp due to tactile defensiveness, the few EEGs that were conducted between the ages of four and six were not considered successful. In her fourth year of life, she started to attend sessions with a physiotherapist. During these appointments, she had examinations conducted on her posture, articulations, and motor development. The passive range of motion in hip abduction was measured in a standard supine position by a goniometer (the range of motion was 45 degrees in the right and left hips). The angle of trunk rotation was measured by a scoliometer in the cervical, cervicothoracic (5 degrees), thoracic, and thoracolumbar spines (10 degrees) by a Bunnel scoliometer (C, T, T-L) [11]. The range of motion in the ankle articulation was measured by a goniometer (20 degrees in right, and 25 in left). Motor function was assessed using the International Classification of Functioning, Disability and Health for Children and Youth (ICF-CY). She could walk up and down the stairs d 4508 (the code of ICF-CY), jump d 4503 (the code of ICF-CY), and kick a ball d 4351 (the code of ICF-CY).
Figure 1

Coronal B (T2-weighted sequence)—Thicker cortical layer on the right side.

Figure 2

Coronal (T2-weighted sequence)—cyst—at the front of the temporal lobe.

Figure 3

T1-weighted sequence. Cyst modeling temporal lobe.

Figure 4

Coronal (T2-weighted sequence). Slight delayed myelination.

Although the child’s motor development progressed, there were some features that did not fit a diagnosis of ASD. Moreover, the behavior of the child started to worsen despite applying strategies for children with ASD. She started to take off her clothing, put water everywhere, and tear paper repetitively. Due to the girl’s curiosity, a desire for social interaction, spontaneous behaviors, and unsuccessful strategies for children with ASD, the neurologist questioned a diagnosis of ASD. Then, a number of genetic tests were performed in search of an underlying cause of the observed phenotype. The karyotype was 46, XX. The results of the PWS/AS MLPA (multiplex ligation-dependent probe amplification) targeted test, the microarray CGH, and the exome sequencing revealed no known pathogenic variants. Moreover, three variants of uncertain clinical significance (VUS) were identified in the HSD17B4 and in DDX3X genes. Exome sequencing has been performed in BluePrint Gentics OY (Espoo, Finland), a CLIA-certified laboratory (#99D2092375), accredited by the College of American Pathologists (CAP#9257331). This test targeted all protein coding exons, exon-intron boundaries (±20 bps) and selected non-coding, deep intronic variants of the genes included in the Clinical Genomics Database and the Developmental Disorders Genotype-Phenotype Database (DD2GP) comprising > 3750 genes. Besides, an analysis for variants that are not located within known clinically associated genes but have properties that make them candidates for potentially disease-causing variants was performed. The median target region coverage was 108 (99.19 sequences covered ≥ 20×). Please see the Blueprint Genetics webpage for further details [12]. Please see Table 2.
Table 2

Characterization of the Variant of Uncertain Significance (VUS) found in the exome sequencing analysis.

GenePosTranscriptNomenclatureConsequenceGenotypeClassification
HSD17B45:118788281NM_000414.4c.11C>G, p(Pro4Arg)missense_variantHETVariant of uncertain significance
ID GNOMAD POLYPHEN SIFT MUTTASTER
rs14288920952/282304benigntoleratedpolymorphism
OMIM PHENOTYPE INHERITANCE COMMENT
D-bifunctional protein deficiency, AR
Perrault Syndrome
GENE POS TRANSCRIPT NOMENCLATURE CONSEQUENCE GENOTYPE CLASSIFICATION
HSD17B45:118813169NM_001199291.3c.482A>G, (Glu161Gly)missense_variantHETVariant of uncertain significance
ID GNOMAD POLYPHEN SIFT MUTTASTER
0/0Benigntolerateddisease causing
OMIM PHENOTYPE INHERITANCE COMMENT
D-bifunctional protein deficiency, Perrault Syndrome AR
GENE POS TRANSCRIPT NOMENCLATURE CONSEQUENCE GENOTYPE CLASSIFICATION
DDX3XX:41193562NM_001356.4c.45+12G>Aintron_variantHETVariant of uncertain significance
ID GNOMAD POLYPHEN SIFT MUTTASTER
0/175946N/AN/AN/A
OMIM PHENOTYPE INHERITANCE COMMENT
Mental retardation, X-linked 102 X-linked
Subsequently, segregation studies performed on a maternal DNA sample revealed the maternal origin of the two HSD17B4 variants. Accordingly, a diagnosis of the autosomal recessive Perrault syndrome was ruled out given their cis location. Conversely, the variant in DDX3X previously not reported in population databases [13] was found to be absent in the maternal sample and hence likely a de novo event. Even though the paternal sample was not available for co-segregation studies, due to the likely deleterious character of the variant, it is rather improbable that it would originate from the father. Further in-silico analyses suggest its impact on splicing (Figure 5). Experimental verification is currently ongoing.
Figure 5

Visualization of the exon-intron junction for exon 1 of the DDX3X gene for both the wild-type and mutant genomic sequences (ESE-Finder ver 3.0). The canonical splice-site is shown by seizors; The arrows indicate the variant location. In-silico analyses of the impact on splicing. The substitution at +12 leads to significant alterations in the RNA-recognition motifs of the specific serine/arginine-rich proteins.

At three years of age, the patient was presenting with a higher level of arousal and was not adapting well to novel situations. Overall, the child seemed to have severe difficulties with social intelligence and was highly unresponsive to environmental cues at that time [14]. Due to tactile defensiveness, it was extremely difficult to touch the patient [15]. This is why some therapeutic interventions at this point of development could not be implemented. To maintain the ability to have physical contact with the child and to increase the child’s joint attention, proprioceptive and vestibular stimulation were used. Other sensory stimuli were causing “white noise” and destabilized the child [16].

3. Results

The Vineland Adaptive Behavior Scales (VABS), Third Edition (Vineland–III) is a standardized assessment that was published in 2016 by Sara S. Sparrow, Domenic V. Cicchetti, and Celine A. Saulnier [17]. This assessment is largely used with children with IDD, and is not only used in the assessment of these children for the development of domain-specific goals for learning but also to determine the overall strengths and weaknesses of these children across several domains. The clinical team used the Vineland-3 Comprehensive Parent/Caregiver Form Report and assessed the following 11 skill domains for the patient: receptive communication, expressive communication, written, personal, domestic, community, interpersonal relationships, play and leisure, coping skills, gross motor skills, and fine motor skills. For the purposes of this case study, the clinical team chose to report the results of fine and gross motor skills for the patient. While fine motor skills are physical skills that use the small muscles in the hands to manipulate objects, gross motor skills are physical skills that use larger muscles in the arms and legs to carry out movement and coordination. As can be seen in Table 3, the patient in this study scored v-scale scores for the following skills: 1 for receptive (low), 2 for expressive (low), 4 for written (low), 9 for personal (low), 6 for domestic (low), 6 for community (low), 6 for interpersonal (low), 6 for play and leisure (low), 5 for coping (low), 13 for gross motor (moderately low), and 8 for fine motor skills (low). When interpreting the outcomes of this assessment, the assessor used the v-scale score, with scores of 1–9 indicating low, 10–12 indicating moderately low, 13–17 indicating adequate, 18–20 indicating moderately high, and 21–24 indicating high. Overall, motor skills are considered low for the purposes of the VABS.
Table 3

Results of the Vineland-3 assessment of the patient.

Adaptive LevelAge EquivalentV-Scale Score/Standard ScoreRaw ScoreDomain
Low N/A 27 N/A Communication
Low 1:01126Receptive
Low 0:11116Expressive
Low <3:044Written
Low N/A 57 N/A Daily Living Skills
Low 3:00960Personal
Low <3:060Domestic
Low <3:066Community
Low N/A 46 N/A Socialization
Low 0:09625Interpersonal Relationships
Low 0:09512Play and Leisure
Low <2:056Coping Skills
Moderately Low N/A 74 N/A Motor
Moderately Low 5:001381Gross Motor Skills
Low 2:11837Fine Motor Skills
Low N/A 49 N/A Adaptive Behavior Composite
Nowadays, thanks to an appropriate genetic diagnosis, behavioral therapy, and appointments with neurologists, the girl has started to have more structure during therapy. She began to attend a kindergarten that is not just for children with ASD but also for children with other dysfunctions. She also started to attend hippo-therapy. Her obsessive behaviors, relating to cutting paper and playing with water, are now rare. She started to have interactions with other children during classes.

4. Discussion

Early diagnosis is a very important aspect of treating children, especially those with very rare diseases. An example is the individual described in this case study. The DDX3X gene has 69 transcripts (splice variants; ENSEMBL accessed December 2021), which may be the mechanism of regulation of its activity in human tissues, since the encoded proteins vary in their sequence and activity. Alteration of splicing, especially at intron 1, may lead to impairment of the collective network of transcripts and result in the IDD/ASD phenotype. The patient initially received a diagnosis of ASD as the result of a psychological test at three years of age, and this had an implication in her everyday life. She started to attend a kindergarten for children with ASD, and there her behavior started to regress. It seemed that a psychological diagnosis should be based not only on observation but also on validated tests. An EEG was performed at the age of six, when she was suspected of Rett-like disease or Angelman syndrome due to a fascination with water and possessing blond hair and blue eyes. The girl had the ability to spontaneously explore her environment and be sociable despite presenting with delays in receptive and expressive communication. The DECIPHER database describes the appearance of “cumulative faces” for a patient with DDX3X, such as a wide nose bridge and narrow hypoplastic wings. We observe these same characteristics in our patient [7]. The WES test sheds a new light on the case and in this sense cannot be overestimated when it comes to the correct diagnosis of children with autistic-like behaviors. This is the first study to report a case of a Polish individual with a DDX3X-associated disorder. The presence of asymmetry in the spine has not been observed in any previous subjects diagnosed with DDX3X syndrome [8]. Changes in the temporal lobe have not yet been detected in previous studies, and that is why we provided MRI scans. The inflammatory cytokine profile is high in IL-1β, IL-6, IL-10 and shows inflammation in the body, and it has not been reported yet in the medical literature or in any DDX3X case. The results of the WES allowed for an end to the diagnostic journey of the presented seven-year-old nonverbal female with delayed psychomotor development. The identified novel variant in the DDX3X is most likely affecting the splicing of the gene and leading to an abnormal expression of gene transcripts. The present report emphasizes the clinical utility of exome sequencing in preventing incorrect diagnoses of ASD, cerebral palsy, Rett syndrome, Dandy–Walker syndrome, or an idiopathic diagnosis of IDD. Future observation and treatment should focus on the patient’s speech and will be described and emphasized in a future study.

5. Conclusions

In reference to our findings, we suggest a genetic diagnosis for each female with a recent diagnosis of ASD who presents with an atypical phenotype, musculoskeletal problems, pathological changes in MR, and behaviors that do not completely conform to a diagnosis of ASD. Thanks to a proper genetic diagnosis, a proper assessment and treatment can be applied. This enables the proper development of a child with DDX3X.

Limitations of the Study

A limitation of this study is to have described only one female with DDX3X. However, it is still a very rare disease.
  12 in total

1.  De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.

Authors:  Pantelis Nicola; Patrick R Blackburn; Kristen J Rasmussen; Nicole L Bertsch; Eric W Klee; Linda Hasadsri; Pavel N Pichurin; Julia Rankin; F Lucy Raymond; Jill Clayton-Smith
Journal:  Am J Med Genet A       Date:  2019-02-07       Impact factor: 2.802

2.  The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.

Authors:  Bengt Phung; Maciej Cieśla; Adriana Sanna; Nicola Guzzi; Giulia Beneventi; Phuong Cao Thi Ngoc; Martin Lauss; Rita Cabrita; Eugenia Cordero; Ana Bosch; Frida Rosengren; Jari Häkkinen; Klaus Griewank; Annette Paschen; Katja Harbst; Håkan Olsson; Christian Ingvar; Ana Carneiro; Hensin Tsao; Dirk Schadendorf; Kristian Pietras; Cristian Bellodi; Göran Jönsson
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

3.  A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication.

Authors:  Anna Garbelli; Sandra Beermann; Giulia Di Cicco; Ursula Dietrich; Giovanni Maga
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

4.  Noli Me Tangere: Social Touch, Tactile Defensiveness, and Communication in Neurodevelopmental Disorders.

Authors:  Daniela Smirni; Pietro Smirni; Marco Carotenuto; Lucia Parisi; Giuseppe Quatrosi; Michele Roccella
Journal:  Brain Sci       Date:  2019-12-12

5.  A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.

Authors:  Giada Moresco; Jole Costanza; Carlo Santaniello; Ornella Rondinone; Federico Grilli; Elisabetta Prada; Simona Orcesi; Ilaria Coro; Anna Pichiecchio; Paola Marchisio; Monica Miozzo; Laura Fontana; Donatella Milani
Journal:  Ital J Pediatr       Date:  2021-03-31       Impact factor: 2.638

6.  DDX3X and DDX3Y are redundant in protein synthesis.

Authors:  Srivats Venkataramanan; Margaret Gadek; Lorenzo Calviello; Kevin Wilkins; Stephen N Floor
Journal:  RNA       Date:  2021-09-17       Impact factor: 4.942

7.  Effect of Short-Term Deep-Pressure Portable Seat on Behavioral and Biological Stress in Children with Autism Spectrum Disorders: A Pilot Study.

Authors:  Ilham Yustar Afif; Muhammad Farkhan; Ojo Kurdi; Mohamad Izzur Maula; Muhammad Imam Ammarullah; Budi Setiyana; J Jamari; Tri Indah Winarni
Journal:  Bioengineering (Basel)       Date:  2022-01-20

8.  Assessment of anterior-posterior spinal curvatures in children suffering from hypopituitarism.

Authors:  Magdalena Kobylińska; Roksana Malak; Katarzyna Majewska; Andrzej Kędzia; Włodzimierz Samborski
Journal:  BMC Endocr Disord       Date:  2019-12-11       Impact factor: 2.763

Review 9.  DDX3X: structure, physiologic functions and cancer.

Authors:  Jie Mo; Huifang Liang; Chen Su; Pengcheng Li; Jin Chen; Bixiang Zhang
Journal:  Mol Cancer       Date:  2021-02-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.